7.2 Specimen Quality Assessment & Rejection

7.2 Specimen Quality Assessment & Rejection

When a specimen arrives in the clinical laboratory, it undergoes rigorous inspection prior to analysis. If pre-analytical errors compromise sample integrity, the specimen must be formally rejected and recollected. Phlebotomists must understand why specimens are rejected and master Point-of-Care Testing (POCT) quality control procedures.

Specimen Rejection Criteria (Pre-Analytical Errors)

Laboratory specimen rejection is a vital patient safety defense. Analyzing a compromised specimen yields inaccurate diagnostic data that can lead to misdiagnosis, incorrect drug dosing, or inappropriate medical intervention.

Primary Reasons for Specimen Rejection

1. Unlabeled or Mislabeled Tubes: Absolute zero-tolerance policy. If a tube lacks required identifiers or if label data mismatches the requisition, the tube MUST be rejected. No one is permitted to relabel an unlabeled tube post-collection.
2. Hemolyzed Specimen: Ruptured erythrocytes release intracellular constituents into plasma/serum, turning it pink or red. Causes false elevation of Potassium ($K^+$), LDH, AST, Iron, and Magnesium.
3. Clotted Specimen in Anticoagulated Tube: Micro-clots or macro-clots in EDTA (Lavender) or Sodium Citrate (Light Blue) tubes indicate inadequate inversion mixing. Clots consume fibrinogen and platelets, invalidating CBC and coagulation results.
4. Quantity Not Sufficient (QNS): Inadequate blood volume collected for the required additive ratio.
   • Light Blue Top (Sodium Citrate): Demands a strict 9:1 blood-to-anticoagulant ratio (90% blood, 10% liquid citrate). Under-filling results in excess free citrate binding calcium in the test system, causing falsely prolonged Prothrombin Time (PT/INR) and Partial Thromboplastin Time (PTT).
5. Incorrect Tube Type / Additive: Drawing a lavender tube instead of a green tube for chemistry panels.
6. Expired Tube Used: Expired evacuated tubes lose vacuum (causing under-filling) and experience additive degradation.
7. Contaminated Specimen: Drawing blood above an active intravenous (IV) line dilutes the specimen with IV fluid (dextrose, saline) or contaminates it with heparin.

+-------------------------------------------------------------------------+
|                    PRE-ANALYTICAL REJECTION SUMMARY                     |
+-------------------------------------------------------------------------+
| Rejection Reason      | Root Cause                  | Impact            |
+-----------------------+-----------------------------+-------------------+
| Mislabeled Tube       | Bedside protocol failure    | Absolute Rejection|
| Hemolysis             | Shaking / Small needle      | False High K+/LDH |
| Clotted EDTA          | Under-inversion             | Invalid CBC       |
| QNS Light Blue (<90%) | Early pull / Vacuum loss    | False High PT/INR |
| IV Contamination      | Drawn above IV line         | False High Glucose|
+-------------------------------------------------------------------------+

Visual Inspection & Interference Indices

Following centrifugation, serum or plasma is visually evaluated against three primary visual interference indices: Hemolysis, Lipemia, and Icterus.

+-------------------------------------------------------------------------+
|                   SERUM / PLASMA VISUAL INTERFERENCE                    |
+-------------------------------------------------------------------------+
| Normal Serum:      Clear, Pale Yellow / Straw Color                     |
| Hemolyzed Serum:   Clear to Cloudy, Pink to Deep Red                    |
| Lipemic Serum:     Opaque, Milky White / Turbid                         |
| Icteric Serum:     Clear, Dark Yellow to Deep Amber / Brown-Green       |
+-------------------------------------------------------------------------+

1. Hemolysis Index (Pink to Red)

• Appearance: Clear to cloudy serum/plasma displaying a pink, bright red, or dark ruby tint.
• Cause: Hemoglobin released from ruptured red blood cells. Common collection causes include using too small a needle (e.g., 25-gauge), pulling syringe plungers back forcefully, drawing through a hematoma, vigorous tube shaking, or centrifuging unclotted blood.
• Analyte Interference:
  • Severely Falsely Elevated: Potassium ($K^+$), Lactate Dehydrogenase (LDH), Aspartate Aminotransferase (AST), Iron, Magnesium, Phosphorus.
  • Falsely Decreased: Red Blood Cell (RBC) count, Hematocrit (Hct).

2. Lipemia Index (Milky White)

• Appearance: Opaque, turbid, cloudy, or milky-white serum or plasma.
• Cause: High concentration of lipids (triglycerides) and chylomicrons. Typically caused by drawing blood shortly after a high-fat meal (post-prandial specimen) or severe hypertriglyceridemia.
• Analyte Interference: Cloudiness scatters light in automated spectrophotometric analyzers, interfering with absorbance readings for hemoglobin, total protein, and electrolyte assays.

3. Icterus Index (Dark Amber / Brown)

• Appearance: Clear, dark yellow, deep amber, or brownish-green serum or plasma.
• Cause: Excessively high concentration of bilirubin resulting from liver disease, hepatitis, biliary obstruction, or hemolytic anemia.
• Analyte Interference: High bilirubin alters colorimetric reactions in creatinine, total protein, and cholesterol testing.

Point-of-Care Testing (POCT) & Quality Control (QC)

Point-of-Care Testing (POCT)—also called bedside or near-patient testing—refers to diagnostic testing performed directly at the site of patient care rather than in a central laboratory. POCT delivers rapid turnaround times for immediate clinical decision-making.

Common POCT Procedures

• Bedside Blood Glucose: Capillary blood via fingerstick used to monitor diabetic glycemic control.
• Coagulation Monitoring (PT/INR): Portable coagulometers measuring prothrombin time for patients taking Warfarin (Coumadin).
• Hemoglobin & Hematocrit (H&H): Microhematocrit cuvettes evaluating anemia or acute blood loss.
• Cardiac Troponin (Rapid Troponin I/T): Bedside immunoassay evaluating suspected acute myocardial infarction.
• Urine Dipstick & Pregnancy (hCG): Rapid enzymatic reagent strips and lateral flow hCG assays.
• Fecal Occult Blood Test (FOBT / Guaiac): Screening for occult gastrointestinal bleeding.

+-------------------------------------------------------------------------+
|                   POCT QUALITY CONTROL (QC) PROTOCOL                    |
+-------------------------------------------------------------------------+
|   [ Start of Testing Shift ]                                            |
|   +-----------------------------------------------------------------+   |
|   | Run Liquid QC Controls: Level 1 (Low) & Level 2 (High)          |   |
|   +-----------------------------------------------------------------+   |
|                                   |                                     |
|                  +----------------+----------------+                    |
|                  |                                 |                    |
|          [ QC Passes ]                     [ QC Fails ]                 |
|                  |                                 |                    |
|        Proceed with Patient              STOP! Do NOT test              |
|               Testing                    Patients. Troubleshoot!        |
+-------------------------------------------------------------------------+

Quality Control (QC) & Calibration Rules

To ensure POCT accuracy, clinical personnel must strictly adhere to CLIA-mandated Quality Control (QC) protocols:

1. Daily Liquid Control Testing: Run manufactured liquid control solutions containing known target values at two distinct levels:
   • Level 1 (Low Control Solution): Verifies analyzer accuracy at abnormally low analyte concentrations.
   • Level 2 (High Control Solution): Verifies analyzer accuracy at abnormally high analyte concentrations.
2. Frequency of QC: QC controls must be run at the start of every shift, whenever opening a new lot of test strips/reagents, following instrument maintenance, or after dropping an analyzer.
3. Out-of-Control Action Rule: If liquid QC values fall outside acceptable target ranges specified by the manufacturer, NO PATIENT SAMPLES MAY BE TESTED. The phlebotomist must document the out-of-control result, re-run controls with a new reagent strip, recalibrate, or remove the analyzer from clinical service until resolved.
4. Maintenance Logs: Operators must document daily QC results, cleaning schedules, temperature logs for storage units ($2^\circ\text{C}$ to $8^\circ\text{C}$ for strip refrigeration), and electronic calibration records.